These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35074483)

  • 21. Site-Directed Mutagenesis of the Fibronectin Domains in Insulin Receptor-Related Receptor.
    Deyev IE; Chachina NA; Zhevlenev ES; Petrenko AG
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29156593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of a second ligand binding site of the insulin receptor.
    Hao C; Whittaker L; Whittaker J
    Biochem Biophys Res Commun; 2006 Aug; 347(1):334-9. PubMed ID: 16814253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin and epidermal growth factor receptor family members share parallel activation mechanisms.
    Ferguson KM; Hu C; Lemmon MA
    Protein Sci; 2020 Jun; 29(6):1331-1344. PubMed ID: 32297376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional selectivity of insulin receptor revealed by aptamer-trapped receptor structures.
    Kim J; Yunn NO; Park M; Kim J; Park S; Kim Y; Noh J; Ryu SH; Cho Y
    Nat Commun; 2022 Oct; 13(1):6500. PubMed ID: 36310231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A hotspot for enhancing insulin receptor activation revealed by a conformation-specific allosteric aptamer.
    Yunn NO; Park M; Park S; Lee J; Noh J; Shin E; Ryu SH
    Nucleic Acids Res; 2021 Jan; 49(2):700-712. PubMed ID: 33410883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dimeric states of transmembrane domains of insulin and IGF-1R receptors: Structures and possible role in activation.
    Kuznetsov AS; Zamaletdinov MF; Bershatsky YV; Urban AS; Bocharova OV; Bennasroune A; Maurice P; Bocharov EV; Efremov RG
    Biochim Biophys Acta Biomembr; 2020 Nov; 1862(11):183417. PubMed ID: 32710851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-affinity insulin binding: insulin interacts with two receptor ligand binding sites.
    Whittaker L; Hao C; Fu W; Whittaker J
    Biochemistry; 2008 Dec; 47(48):12900-9. PubMed ID: 18991400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic activation of the insulin receptor via two distinct sites.
    Li J; Park J; Mayer JP; Webb KJ; Uchikawa E; Wu J; Liu S; Zhang X; Stowell MHB; Choi E; Bai XC
    Nat Struct Mol Biol; 2022 Apr; 29(4):357-368. PubMed ID: 35361965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transmembrane domain interactions are necessary for negative cooperativity of the insulin receptor.
    Whittaker J; Garcia P; Yu GQ; Mynarcik DC
    Mol Endocrinol; 1994 Nov; 8(11):1521-7. PubMed ID: 7877620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel approach to identify two distinct receptor binding surfaces of insulin-like growth factor II.
    Alvino CL; McNeil KA; Ong SC; Delaine C; Booker GW; Wallace JC; Whittaker J; Forbes BE
    J Biol Chem; 2009 Mar; 284(12):7656-64. PubMed ID: 19139090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Docking of insulin to a structurally equilibrated insulin receptor ectodomain.
    Vashisth H; Abrams CF
    Proteins; 2010 May; 78(6):1531-43. PubMed ID: 20112420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Architecture of autoinhibited and active BRAF-MEK1-14-3-3 complexes.
    Park E; Rawson S; Li K; Kim BW; Ficarro SB; Pino GG; Sharif H; Marto JA; Jeon H; Eck MJ
    Nature; 2019 Nov; 575(7783):545-550. PubMed ID: 31581174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous Dimerization and Distinct Packing Modes of Transmembrane Domains in Receptor Tyrosine Kinases.
    Levintov L; Gorai B; Vashisth H
    Biochemistry; 2024 Oct; 63(20):2692-2703. PubMed ID: 39322977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucose binds to the insulin receptor affecting the mutual affinity of insulin and its receptor.
    Root-Bernstein R; Vonck J
    Cell Mol Life Sci; 2009 Aug; 66(16):2721-32. PubMed ID: 19554259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of insulin receptor dimerization domains in ligand binding, cooperativity, and modulation by anti-receptor antibodies.
    Surinya KH; Molina L; Soos MA; Brandt J; Kristensen C; Siddle K
    J Biol Chem; 2002 May; 277(19):16718-25. PubMed ID: 11875066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mapping of alkali-sensing sites of the insulin receptor-related receptor. The role of L2 and fibronectin domains.
    Deyev IE; Chachina NA; Shayahmetova DM; Serova OV; Petrenko AG
    Biochimie; 2015 Apr; 111():1-9. PubMed ID: 25597417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding the mechanism of insulin and insulin-like growth factor (IGF) receptor activation by IGF-II.
    Alvino CL; Ong SC; McNeil KA; Delaine C; Booker GW; Wallace JC; Forbes BE
    PLoS One; 2011; 6(11):e27488. PubMed ID: 22140443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin/receptor binding: the last piece of the puzzle? What recent progress on the structure of the insulin/receptor complex tells us (or not) about negative cooperativity and activation.
    De Meyts P
    Bioessays; 2015 Apr; 37(4):389-97. PubMed ID: 25630923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular mechanisms of cytokine receptor activation.
    Grötzinger J
    Biochim Biophys Acta; 2002 Nov; 1592(3):215-23. PubMed ID: 12421667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A structurally minimized yet fully active insulin based on cone-snail venom insulin principles.
    Xiong X; Menting JG; Disotuar MM; Smith NA; Delaine CA; Ghabash G; Agrawal R; Wang X; He X; Fisher SJ; MacRaild CA; Norton RS; Gajewiak J; Forbes BE; Smith BJ; Safavi-Hemami H; Olivera B; Lawrence MC; Chou DH
    Nat Struct Mol Biol; 2020 Jul; 27(7):615-624. PubMed ID: 32483339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.